M. Abdul-Hay

发表

T-cell lymphomas, a challenging disease: types, treatments, and future

Helen Ma, M. Abdul-Hay, 2016, International Journal of Clinical Oncology.

Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.

M. Abdul-Hay, A. Desai, Hassan El-Bakkar, 2015, Clinical lymphoma, myeloma & leukemia.

Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature

M. Abdul-Hay, L. Naymagon, 2019, Journal of Medical Case Reports.

Prescreening to Increase Therapeutic Oncology Trial Enrollment at the Largest Public Hospital in the United States

A. Balar, M. Abdul-Hay, K. Joseph, 2021, JCO oncology practice.

Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report

M. Abdul-Hay, Nicholas D. Ward, Edward T. Carey, 2022, Journal of Medical Case Reports.

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults

Cosmin A. Tegla, Frank Cirrone, M. Abdul-Hay, 2020, Clinical hematology international.

Human Herpes Virus-6 Encephalitis Following Autologous Blood and Marrow Transplant

Frank Cirrone, M. Abdul-Hay, J. Azzi, 2019, Clinical hematology international.

Acute lymphoblastic leukemia: a comprehensive review and 2017 update

T Terwilliger, M Abdul-Hay, M. Abdul-Hay, 2017, Blood Cancer Journal.

‘Acute myeloid leukemia: a comprehensive review and 2016 update'

I. de Kouchkovsky, M Abdul-Hay, M. Abdul-Hay, 2016, Blood Cancer Journal.

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant

M. Abdul-Hay, S. Cytryn, 2020, Clinical hematology international.

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.

M. Sznol, M. Ernstoff, L. Fong, 2019, JAMA oncology.

Novel agents in the treatment of multiple myeloma: a review about the future

M. Abdul-Hay, L. Naymagon, 2016, Journal of Hematology & Oncology.

Peripheral T-cell lymphoma: pharmacotherapy overview

J. Zain, M. Abdul-Hay, 2012 .

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation

Frank Cirrone, L. Luznik, M. Abdul-Hay, 2020, Frontiers in Immunology.

A Challenging Blastic Plasmacytoid Dendritic Cell Neoplasm Case: Tough Decisions to Make

M. Abdul-Hay, Joseph Han, Faisal Huq-Ronny, 2017, Journal of hematology.

A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3

D. Levy, D. Gough, C. White, 2015, Molecular and Cellular Biology.

Immunicy-1: Targeting BCMA with Cyad-211 to Establish Proof of Concept of an shRNA-Based Allogeneic CAR T Cell Therapy Platform

G. Morgan, J. Brayer, C. Lonez, 2021, Blood.

PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

J. Goldberg, Frank Cirrone, B. Bruno, 2023, Blood advances.

Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.

J. Hernández-Rivas, G. Zugmaier, C. Berthon, 2024, American journal of hematology.

Immunomodulatory drugs for the treatment of periorbital necrobiotic xanthogranuloma.

M. Abdul-Hay, 2013, Clinical advances in hematology & oncology : H&O.

Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia

M. Abdul-Hay, Mihir Shukla, Jun H. Choi, 2024, Biomedicines.

A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring KMT2A or NPM1 Alterations

E. Jabbour, I. Aldoss, C. Récher, 2023, Blood.

Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future

M. Abdul-Hay, J. Choi, Mihir A. Shukla, 2023, Acta Haematologica.